Comment by
Insightful1 on Feb 04, 2022 5:16pm
I would be suprised if MedX wasn't having discussions with all the major teleheath companies and pharmacies because they cannot assess pigmented lesions. This would be a perfect fit. I am sure we will continue to hear more developments in Q1 as they promised.